Indications for adrenergic stimulators in shock.
D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002339:Carotid Arteries / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003911:Dextrans / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006325:Heart Atria / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy; D007545:Isoproterenol / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects; D008616:Mephentermine / Q000627:therapeutic use; D008680:Metaraminol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D012769:Shock / Q000188:drug therapy*; D012770:Shock, Cardiogenic / Q000188:drug therapy; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy; D012965:Sodium Chloride / Q000008:administration & dosage; D013566:Sympathomimetics / Q000627:therapeutic use*
D003911:Dextrans; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D012965:Sodium Chloride; D008680:Metaraminol; D007545:Isoproterenol; D008616:Mephentermine; D009638:Norepinephrine; D004837:Epinephrine